15.04
price down icon3.28%   -0.51
after-market After Hours: 15.04
loading

Centessa Pharmaceuticals Plc Adr Stock (CNTA) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Interest Income/Expense
1.60%
2.529
2.57 2.541 2.45 2.345
Operating Income/Loss
2.59%
-36.09
-35.18 -40.21 -47.02 -48.88
Income/Loss From Continuing Operations Before Tax
5.24%
-37.56
-35.69 -41.47 -48.94 -50.04
Income Tax Expense/Benefit, Deferred
391.28%
0.434
-0.149 -2.89 - -
Income Tax Expense/Benefit
57.95%
0.481
1.144 -2.826 -24.05 0.677
Income/Loss From Continuing Operations After Tax
3.28%
-38.05
-36.84 -38.65 -24.89 -50.71
Net Income/Loss
3.28%
-38.05
-36.84 -38.65 -24.89 -50.71
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
16,876%
99.89
0.5884 96.65 95.16 94.94
Diluted Average Shares
16,876%
99.89
0.5884 96.65 95.16 94.94
Basic Earnings Per Share
2.70%
-0.38
-0.37 -0.40 -0.26 -0.53
Diluted Earnings Per Share
2.70%
-0.38
-0.37 -0.40 -0.26 -0.53
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$76.29
price down icon 6.45%
$22.96
price up icon 1.23%
$33.86
price up icon 0.65%
$19.13
price down icon 7.54%
biotechnology ONC
$245.53
price down icon 9.67%
$111.56
price down icon 1.20%
Cap:     |  Volume (24h):